Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Guidant Contak CD/TR

This article was originally published in The Gray Sheet

Executive Summary

Pulse generators for treatment of congestive heart failure debut on the European market. While both provide biventricular stimulation and bradycardia pacing, the CD model also offers cardioversion/defibrillation therapies for tachycardia. The devices use the Easytrak transvenous, over-the-wire lead system to reach the left side of the heart. The market release makes Guidant "the first company to provide a full product line of implantable devices for the treatment of heart failure," the firm maintains

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel